0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV40.05%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier26DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.67Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MeiraGTx Holdings Stock Discussion
MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi -4/sh
MeiraGTx Holdings plc (Nasdaq: MGTX), a clinical stage genetic medicine company, has announced the pricing of an underwritten offering of 12,500,000 ordinary shares at $4.00 per share. The offering, expected to close on August 13, 2024, aims to raise $50 million in gross proceeds. Sanofi led the financing with a $30 million equity investment, joined by Perceptive Advisors and other inst...
Dow Jones· just
5 MINUTES AGO, 7:30 AM EST
VIA PR NEWSWIRE
Sanofi to make a strategic equity investment in Graviton Bioscience Corporation
• Sanofi to receive a 12-month right of first negotiation (ROFN) to explore collaboration opportunities spanning multiple indications, including immunological and metabolic syndrome indications
Will slowly accumulate dips in this name
Last big buyout was $PRVB for my portfolio where Sanofi had invested dollars before FDA decision
No comment yet